Clinical Trials on Bladder Dysfunction in China

Total 643 results

Sun Yat-sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

The Early Diagnosis and Warning Role of Erectile Dysfunction

Erectile Dysfunction | Endothelial Dysfunction

China
Fuda Cancer Hospital, Guangzhou
Guangzhou Four-Leaf Clover HealthTech Co., Ltd.

Withdrawn

Very Small Embryonic-like Stem Cells for Erectile Dysfunction

Organic Erectile Dysfunction

China
First Affiliated Hospital, Sun Yat-Sen University

Unknown

The Value of Enhanced External Counterpulsation on Erectile Dysfunction (EECPED)

Erectile Dysfunction

China
Nanjing Medical University

Unknown

Differential Plasma MicroRNA Profiles in ED and Normal Erectile Function in Older Males

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Effect of TPN171H on Spermatogenesis

Erectile Dysfunction

China
Eli Lilly and Company
ICOS Corporation

Completed

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Impotence

China
Vigonvita Life Sciences

Completed

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

Erectile Dysfunction | Alcohol | Phosphodiesterase Inhibitor

China
Bayer

Completed

BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.

Erectile Dysfunction

China
Hospital Authority, Hong Kong
The University of Hong Kong

Completed

A Randomized Controlled Trial on Smoking Cessation and Adherence Intervention on Patients With Erectile Dysfunction

Smoking Cessation

China
First Affiliated Hospital, Sun Yat-Sen University
Dongguan Taiping People's Hospital

Unknown

Male Reproductive Health of Floating Population: a Large-Scale Survey in Dongguan

Erectile Dysfunction | Premature Ejaculation | Sexual Behavior

China
Vigonvita Life Sciences

Completed

Drug-Drug Interaction (DDI) Study for TPN171H

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

Erectile Dysfunction

China
Yangtze River Pharmaceutical Group Co., Ltd.

Completed

A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol

Erectile Dysfunction

China
The First Hospital of Jilin University

Recruiting

Erectile Dysfunction, Psychological Disorders, and Sexual Performance Among Men Seeking Medical Help for Fertility

Sexual Dysfunction | Erectile Dysfunction | Premature Ejaculation | Infertile Men | Fertile Men | Wife's Miscarriage

China
Eli Lilly and Company

Completed

A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China

Erectile Dysfunction

China
Peking University First Hospital

Recruiting

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Urinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, Bladder

China
Vigonvita Life Sciences

Completed

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Erectile Dysfunction

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Peking University Third Hospital

Not yet recruiting

Urinary Continence of Female POPRC and OIN

Urinary Bladder Neoplasms | Urinary Incontinence | Sexual Dysfunction, Physiological | Treatment Outcome | Woman

China
Hospital Authority, Hong Kong

Completed

Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS

Prostatic Hyperplasia | Impotence

China
Eli Lilly and Company

Completed

A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction

Erectile Dysfunction

China
Bayer

Completed

REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy

Erectile Dysfunction

Poland, China, Croatia, France, Germany, Hungary, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Thailand
Tianjin Medical University Second Hospital
CSPC Pharmaceutical Group Limited

Unknown

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Muscle Invasive Bladder Cancer

China
Ruijin Hospital

Not yet recruiting

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Muscle-Invasive Bladder Carcinoma

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients (ASCERTAIN)

Non-muscle Invasive Bladder Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Active, not recruiting

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients (ACCRUE)

Non-muscle Invasive Bladder Cancer

China
Peking University

Withdrawn

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Invasive Bladder Cancer Stage IV

China
Beijing Pins Medical Co., Ltd
Beijing Hospital

Unknown

Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)

Refractory Overactive Bladder

China
China Rehabilitation Research Center

Unknown

A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury (SCI)

Erectile Dysfunction

China
Ruijin Hospital

Not yet recruiting

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Non-muscle-invasive Bladder Cancer

China
Chinese PLA General Hospital
Beijing GeneX Health Technology Co., Ltd

Recruiting

Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection

Muscle-Invasive Bladder Carcinoma

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males (NPTR)

Erectile Dysfunction

China
Zhujiang Hospital

Recruiting

Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

Urinary Bladder Cancer

China
RenJi Hospital

Recruiting

Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer

Urothelial Carcinoma Bladder | PD-1 Inhibitor

China
Tianjin Medical University Second Hospital

Recruiting

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Muscle Invasive Bladder Cancer Urothelial Carcinoma

China
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URL

Urolithiasis | Overactive Bladder Syndrome

China
The First Affiliated Hospital of Hunan University...

Recruiting

Clinical Efficacy of Acupuncture on the Liver Meridian in Men With Erectile Dysfunction Reserve (GJZLBQGNZA)

Erectile Dysfunction | Acupuncture Therapy | Median Nerve Disease

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Bladder Cancer

China
Third Military Medical University

Unknown

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Bladder Cancer

China
Southwest Hospital, China

Unknown

Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer

Bladder Cancer

China
RenJi Hospital
BeiGene; RemeGen Co., Ltd.

Recruiting

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

HER2 | Non-Muscle Invasive Bladder Cancer

China
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BL-PDT-RCT)

Non-muscle-invasive Bladder Cancer

China
Fudan University

Recruiting

Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer

Bladder Cancer

China
Peking University Third Hospital

Unknown

Multidisciplinary Bladder-preservation Therapy for Bladder Cancer

Bladder Cancer

China
Zhujiang Hospital

Recruiting

RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Bladder Cancer | Muscle-Invasive Bladder Carcinoma

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

High-risk Non-muscle Invasive Bladder Cancer

China
Binhui Biopharmaceutical Co., Ltd.

Recruiting

OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer

Non-muscle-invasive Bladder Cancer

China
Fudan University

Recruiting

CD155 in Bladder Cancer

Bladder Cancer

China
Tianjin Medical University Second Hospital

Recruiting

A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

Bladder Urothelial Carcinoma

China
Shanghai Pudong Hospital

Recruiting

An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

Recurrent or Metastatic Bladder Cancer

China

3

Subscribe